PFaahfaahinta muuqaalka:
Muuqashada | Budada crystal cad ama ka baxsan |
Luminta qalajinta | In aan ka badnayn 1.0% |
Sulfate dambas | In aan ka badnayn 1.0% |
L-lysine | In aan ka badnayn 1.2% |
Wareeg gaar ah (C=1 2N gudaha HCL) | +16° ilaa +20° |
Biyo | In aan ka badnayn 0.5% |
Qiimayn | 99.0% ilaa 101.0% |
Kaydinta | Ku hay meel mugdi ah, ku xidhan meel engegan, heerkulka qolka |
Xidhmada | 25kg/ durbaan |
Muddada ansaxinta | 2 sano |
Gaadiidka | bad ama hawo ama dhul |
Dalka Asal ahaan | Shiinaha |
Shuruudaha lacag-bixinta | T/T |
La mid ah:
Nε-Trifluoroacetyl-L-lysine;
(2S)-2-amino-6-[(2,2,2-trifluoroacetyl) amino] hexanoic acid;
(S)-2-Amino-6-pivalamidohexanoic acid;
N6-Trifluoroacetyl-L-lysine;
Nepsilon-Trifluoroacetyl-L-lysine;
N (6) - trifluoroacetyl-L-lysine;
ε-TFA-lysine;
Codsiga:
Waxa loo istcimaalay dhex dhexaadinta daawada lisinopril.
Sareeye:
1. Sida caadiga ah waxaanu haysanaa heerka ton ee kaydka, waxaanan u keeni karnaa alaabta si dhakhso ah ka dib markaan helno dalabka.
2. Tayo sare leh & qiimo tartan ah ayaa la bixin karaa.
3. Warbixinta falanqaynta tayada (COA) ee dufcada shixnadda ayaa la bixin doonaa ka hor inta aan la soo rarin.
4. Su'aalaha alaab-qeybiyaha iyo dukumentiyada farsamada waa la bixin karaa haddii la codsado ka dib marka la buuxiyo qadar go'an.
5. Adeegga iibka ka dib ama dammaanad qaadka weyn: Su'aashaada mid kasta ayaa lagu xallin doonaa sida ugu dhakhsaha badan.